4-81046456-G-C
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_001201.5(BMP3):c.1035G>C(p.Lys345Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00426 in 1,614,052 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.010 ( 18 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 32 hom. )
Consequence
BMP3
NM_001201.5 missense
NM_001201.5 missense
Scores
1
8
9
Clinical Significance
Conservation
PhyloP100: 1.15
Genes affected
BMP3 (HGNC:1070): (bone morphogenetic protein 3) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein suppresses osteoblast differentiation, and negatively regulates bone density, by modulating TGF-beta receptor availability to other ligands. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=0.008763164).
BP6
?
Variant 4-81046456-G-C is Benign according to our data. Variant chr4-81046456-G-C is described in ClinVar as [Benign]. Clinvar id is 774615.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr4-81046456-G-C is described in Lovd as [Likely_benign].
BS1
?
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.01 (1526/152302) while in subpopulation AFR AF= 0.0284 (1182/41556). AF 95% confidence interval is 0.0271. There are 18 homozygotes in gnomad4. There are 746 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
?
High AC in GnomAd at 1512 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BMP3 | NM_001201.5 | c.1035G>C | p.Lys345Asn | missense_variant | 2/3 | ENST00000282701.4 | |
BMP3 | XM_006714291.4 | c.1035G>C | p.Lys345Asn | missense_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BMP3 | ENST00000282701.4 | c.1035G>C | p.Lys345Asn | missense_variant | 2/3 | 1 | NM_001201.5 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00994 AC: 1512AN: 152184Hom.: 17 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
1512
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00424 AC: 1064AN: 250836Hom.: 13 AF XY: 0.00370 AC XY: 501AN XY: 135546
GnomAD3 exomes
AF:
AC:
1064
AN:
250836
Hom.:
AF XY:
AC XY:
501
AN XY:
135546
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00366 AC: 5355AN: 1461750Hom.: 32 Cov.: 34 AF XY: 0.00357 AC XY: 2599AN XY: 727166
GnomAD4 exome
AF:
AC:
5355
AN:
1461750
Hom.:
Cov.:
34
AF XY:
AC XY:
2599
AN XY:
727166
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0100 AC: 1526AN: 152302Hom.: 18 Cov.: 32 AF XY: 0.0100 AC XY: 746AN XY: 74470
GnomAD4 genome
?
AF:
AC:
1526
AN:
152302
Hom.:
Cov.:
32
AF XY:
AC XY:
746
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
13
ALSPAC
AF:
AC:
12
ESP6500AA
AF:
AC:
121
ESP6500EA
AF:
AC:
27
ExAC
?
AF:
AC:
596
Asia WGS
AF:
AC:
20
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Aug 28, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Uncertain
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N
REVEL
Uncertain
Sift
Benign
T
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Loss of glycosylation at P342 (P = 0.0031);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at